Related Experiment Video
Updated: Aug 9, 2026
Three-dimensional Confocal Analysis of Microglia/macrophage Markers of Polarization in Experimental Brain Injury
Published on: September 4, 2013
AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in
J M Schwab1, E Frei, I Klusman
1Institute of Brain Research, University of Tuebingen, Medical School, Calwer Str. 3, D-72076, Tuebingen, Germany. jmschwab@med.uni-tuebingen.de
Abstract:
Microglial cells are among the first and dominant cell types to respond to CNS injury. Following calcium influx, microglial activation leads to a variety of cellular responses, such as proliferation and release of cytotoxic and neurotrophic mediators. Allograft inflammatory factor-1, AIF-1 is a highly conserved EF-handed, putative calcium binding peptide, associated with microglia activation in the brain. Here, we have analyzed the expression of AIF-1 following spinal cord injury at the lesion site and at remote brain regions. Following spinal cord injury, AIF-1+ cells accumulated in parenchymal pan-necrotic areas and perivascular Virchow-Robin spaces. Subsequent to culmination at day 3--a situation characterized by infiltrating blood borne macrophages and microglia activation--AIF-1+ cell numbers decreased until day 7. In remote areas of Wallerian degeneration and delayed neuronal death, a more discrete and delayed activation pattern of AIF-1+ microglia/macrophages reaching maximum levels at day 14 was observed. There was a considerable match between AIF-1+ cells and PCNA (proliferating cell nuclear antigen) or Ki-67+ labeled cells. AIF-1 expression preceded the expression of ED1, thus indicating a pre-phagocytic role. It appears that AIF-1+ microglia/macrophages are among the earliest cells to respond to spinal cord injury. Our results suggest a role of AIF-1 in the initiation of the early microglial response leading to activation and proliferation essential for the acute response to CNS injury. AIF-1 might modulate microgliosis influencing the efficacy of tissue debris removal, myelin degradation, recruitment of oligodendrocytes and re-organisation of the CNS architecture.
Insights
Allograft inflammatory factor-1 (AIF-1) is an early marker of microglial activation following central nervous system (CNS) injury. AIF-1+ cells respond rapidly to spinal cord injury, suggesting a role in the initial stages of neuroinflammation and tissue repair.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglial cells are primary responders to central nervous system (CNS) injury.
- Microglial activation involves calcium influx, proliferation, and mediator release.
- Allograft inflammatory factor-1 (AIF-1) is a calcium-binding protein linked to microglial activation.
Purpose of the Study:
- To analyze AIF-1 expression following spinal cord injury (SCI) at lesion and remote sites.
- To investigate the temporal and spatial patterns of AIF-1+ cells post-SCI.
- To determine the role of AIF-1 in the early microglial response to CNS injury.
Main Methods:
- Immunohistochemical analysis of AIF-1 expression in rat spinal cord tissue post-injury.
- Co-labeling with proliferation markers (PCNA, Ki-67) and macrophage markers (ED1).
- Assessment of AIF-1+ cell distribution and density at different time points post-SCI.
Main Results:
- AIF-1+ cells accumulated at lesion sites and remote areas following SCI.
- Peak AIF-1+ cell numbers occurred at day 3 at the lesion site and day 14 in remote areas.
- AIF-1 expression correlated with proliferation markers and preceded ED1 expression, indicating a pre-phagocytic role.
Conclusions:
- AIF-1+ microglia/macrophages are among the earliest responders to SCI.
- AIF-1 plays a role in initiating microglial activation and proliferation during the acute CNS injury response.
- AIF-1 may influence microgliosis, debris removal, and CNS re-organization.
